Published in Genetics and Environmental Health Week, June 14th, 2006
This trend article about Nagoya City University is an immediate alert from NewsRx to identify developing directions of research.
To "examine the mechanism of resistance to 7-ethyl-10-hydroxycamptothecin (SN-38) in lung cancer," scientists in Japan "continuously exposed the nonsmall-cell lung cancer (NSCLC) cell line NCI-H23 to SN-38 and selected the SN-38-resistant clone H23/SN-38."
"After 2 months of culturing in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Health Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.